These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10934787)

  • 21. Bioequivalence evaluation of two brands of furosemide 40 mg tablets (Salurin and Lasix) in healthy human volunteers.
    Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R
    Biopharm Drug Dispos; 2003 Sep; 24(6):245-9. PubMed ID: 12973821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioequivalence study of two tablet formulations of sildenafil.
    Spínola AC; Almeida S; Filipe A; Tanguay M; Yritia M
    Arzneimittelforschung; 2008; 58(3):122-5. PubMed ID: 18488808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers.
    Dhawan S; Singh B; Garg SK; Hota D; Dash RJ; Singla AK; Sinha VR
    Clin Pharmacokinet; 2006; 45(3):317-24. PubMed ID: 16509763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics and bioavailability of glipizide capsules].
    Chen QC; Yang CQ; Chao CH; Ma YG; Li XN; Chen WL
    Yao Xue Xue Bao; 1995; 30(6):476-80. PubMed ID: 7572185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bioequivalence of piracetam following acute administration of an oral solution or two tablet formulations in volunteers].
    Kummer M; Stadler L
    Arzneimittelforschung; 1986 May; 36(5):839-44. PubMed ID: 3730019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bioequivalence study of two dipyridamole products.
    Arafat T; Saket M; Awad R; Ibrahim H; Saleh M; Gharaibeh M; Sallam E; Shuber M
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):564-7. PubMed ID: 2613391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended release dosage form of glipizide: development and validation of a level A in vitro-in vivo correlation.
    Ghosh A; Bhaumik UK; Bose A; Mandal U; Gowda V; Chatterjee B; Chakrabarty US; Pal TK
    Biol Pharm Bull; 2008 Oct; 31(10):1946-51. PubMed ID: 18827360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence study of 500 mg cefuroxime axetil film-coated tablets in healthy volunteers.
    Kaza M; Leś A; Serafin-Byczak K; Ksycińska H; Rudzki PJ; Gutkowskpi P; Drewniak T; Gutkowska A; Tarasiuk A; Piatkowska-Chabuda E; Skowrońska-Smolak M; Wilkowska E
    Acta Pol Pharm; 2012; 69(6):1356-63. PubMed ID: 23285702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of pharmacokinetic interaction for ISIS 113715, a 2'-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone.
    Geary RS; Bradley JD; Watanabe T; Kwon Y; Wedel M; van Lier JJ; VanVliet AA
    Clin Pharmacokinet; 2006; 45(8):789-801. PubMed ID: 16884318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study on the bioequivalence of two ranitidine formulations.
    Hilgenstock C; Schmiedel G; Bührens KG
    Arzneimittelforschung; 1987 Aug; 37(8):974-6. PubMed ID: 3675698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network].
    Zhang ZH; Wang Y; Wu WF; Zhao X; Sun XC; Wang HQ
    Yao Xue Xue Bao; 2012 Dec; 47(12):1687-95. PubMed ID: 23460977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2005 Jul; 38(4):633-44. PubMed ID: 15967291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetics studies of immediate- and modified-release formulations of glipizide in pigs and dogs.
    Kulkarni R; Yumibe N; Wang Z; Zhang X; Tang CC; Ruterbories K; Cox A; McCain R; Knipp GT
    J Pharm Sci; 2012 Nov; 101(11):4327-36. PubMed ID: 22899546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence of a propylene glycol-based liquid dapsone preparation and dapsone tablets.
    Mirochnick M; Clarke DF; McNamara ER; Cabral H
    Am J Health Syst Pharm; 2000 Oct; 57(19):1775-7. PubMed ID: 11030029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative bioavailability studies on brands of diazepam tablets.
    Ogunbona FA; Adedoyin PA; Olaniyi AA
    Afr J Med Med Sci; 1985; 14(1-2):21-5. PubMed ID: 2994433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide.
    Defang O; Shufang N; Wei L; Hong G; Hui L; Weisan P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):677-85. PubMed ID: 16207615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus.
    Chung M; Kourides I; Canovatchel W; Sutfin T; Messig M; Chaiken RL
    J Clin Pharmacol; 2002 Jun; 42(6):651-7. PubMed ID: 12043953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats.
    Bennett N; Papich MG; Hoenig M; Fettman MJ; Lappin MR
    Am J Vet Res; 2005 Apr; 66(4):581-8. PubMed ID: 15900936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bioequivalence of anvifen and phenibut].
    Zhezlova AV; Belolipetskaia VG; Blagodatskikh SV; Merkulova EV
    Eksp Klin Farmakol; 2011; 74(5):43-4. PubMed ID: 21809698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.